Tag Archive for: Medtech
Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of ViCentra
Experienced MedTech leader to scale manufacturing, drive European expansion, and position the company to enter the US market with the Kaleido insulin patch pump AID system Utrecht, The Netherlands – February 26, 2025 ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest, and most precise insulin patch pump and automated insulin delivery […]
Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval
Enrolment completed – 120 patients with end-stage renal disease in 22 centers in Europe Primary endpoint readouts anticipated in Q2 2025, first market approval expected in 2026 Capability to obtain market approval is further strengthened with the appointment of Rob Eyers as Chief Technology Officer. EINDHOVEN, The Netherlands, 7 January 2025 – Xeltis, a leading […]
Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis
alfapump® is the first US approved active implantable medical device (Class III) for the treatment of recurrent or refractory ascites due to liver cirrhosis PMA Approval and FDA Breakthrough Device Designation US market opportunity estimated at over $2 billion in 2025, growing at 9%[1] due to MASH/NASH[2] and alcoholic liver disease US commercial launch planned for H2 2025 […]
Weekly round-up: Ottimo Pharma Raises over $140 Million in Series A Financing
Ottimo Pharma, a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, on Thursday announced the completion of a Series A financing round of over $140 million. The financing will accelerate the lead asset, Jankistomig, a first-in-class PD1/VEGFR2 bifunctional antibody for multiple solid tumour indications, in both IV and […]
